Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

CAPS Rating: 2 out of 5

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.

Recs

0
Player Avatar otterfolly (< 20) Submitted: 5/26/2010 5:06:04 PM : Outperform Start Price: $3.66 ARIA Score: +334.70

Cambridge brains.

Report this Post Reply

Featured Broker Partners


Advertisement